您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
PD-L1 Recombinant Rat mAb, F(ab')₂ Fragment (SDT-R072)

PD-L1 Recombinant Rat mAb, F(ab')₂ Fragment (SDT-R072)

货号: S0B0103
价格: 600
规格: 0.1mg
介绍: -
其他: -
产品规格
  • 宿主来源

    Rat
  • 抗原名称

    PD-L1, F(AB')₂ FRAGMENT
  • 分子别名

    N/A
  • 免疫原

    N/A
  • 细胞定位

    Membrane
  • Accession

    Q9EP73
  • 克隆号

    SDT-R072
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG2b
  • 应用

    SPR
  • 反应种属 ?

    Ms
  • 纯化方式

    Protein G
  • 浓度

    N/A
  • 标签

    N/A
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4
  • 储存条件

    12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

稀释度
应用 稀释度
SPR 125nM-1.95nM
背景介绍
  • Programmed death-ligand 1 (PD-L1) also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1) is a protein that in humans is encoded by the CD274 gene. Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that has been speculated to play a major role in suppressing the adaptive arm of immune systems during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. The binding of PD-L1 to the inhibitory checkpoint molecule PD-1 transmits an inhibitory signal based on interaction with phosphatases (SHP-1 or SHP-2) via Immunoreceptor Tyrosine-Based Switch Motif (ITSM). This reduces the proliferation of antigen-specific T-cells in lymph nodes, while simultaneously reducing apoptosis in regulatory T cells (anti-inflammatory, suppressive T cells) - further mediated by a lower regulation of the gene Bcl-2. Upregulation of PD-L1 on immune cells (especially myeloid cells) can also lead to formation of an immunosuppressive environment in a highly localized manner that also allow the cancer cells to proliferate.

  • 验证数据

    • Anti-His antibody Immobilized on CM5 Chip captured PD-L1/B7-H1 His Tag, Mouse, can bind PD-L1 Recombinant Rat mAb, F(ab')₂ Fragment (SDT-R072) with an affinity constant of 0.1826 nM as determined in SPR assay.